Pharmaceutical industry is urging government to halt the transfer of nutraceutical oversight from FSSAI to the drug regulatory authority, citing potential market impact
This collaboration aims to expand their complementary nutraceutical portfolios in areas like metabolic care, hospital nutrition, general wellness, women's health, and child nutrition
Nestle India and Dr Reddy's Laboratories Ltd on Thursday announced that they have entered into a definitive agreement to form a joint venture to bring innovative nutraceutical brands to consumers in India and other agreed territories. A joint press release from the companies said the partnership will bring together the well-known global range of nutritional health solutions as well as vitamins, minerals, herbals and supplements of Nestle Health Science (NHSc) with the strong and established commercial strengths of Dr Reddy's in India. The move will help JV partners combine their strengths and grow their complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness , women's health and child nutrition for consumers across India, it said. Select brands will be licensed by the respective companies to the JV company. The Nestl Group will licence brands such as Nature's Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resour
Will tech companies follow Meta's lead on deepfake? Do nutritional supplements need better regulation? Are markets overvalued? How to deactivate and replace Paytm FASTag? All answers here
The government has formed a panel to examine the possibility of bringing nutraceuticals under the ambit of the apex drug regulator CDSCO instead of the food regulator FSSAI to address regulatory challenges and promote consumer safety Presently, the Food Safety and Standards Authority of India (FSSAI) regulates the usage of health supplements and nutraceuticals under the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022. This regulation covers food items that are specially processed or formulated for specific nutritional or dietary purposes, official sources said. Nutraceuticals are products derived from food sources that are believed to provide extra health benefits besides the basic nutritional value found in foods The sources said that the challenges in uniform implementation and enforcement, interchangeable usage of the same nutrient/ingredient at ...
A workshop on natural biopolymers has observed that the demand for nutraceutical products has increased in recent years, resulting in a remarkable growth of the sector with a compound annual growth of 20 per cent over the past three years. This trend is driven by increasing health awareness among the public and a growing emphasis on preventive healthcare. Projections indicate that the nutraceutical market in India will expand from an estimated USD 4 billion to an impressive USD 18 billion by the end of 2025, according to experts, an official release said here on Friday. The workshop was organised by the ICAR-Central Marine Fisheries Research Institute (CMFRI) under the Scientific Social Responsibility (SSR) Policy at the institute. Experts also viewed the increasing demand for nutraceutical products as an indication of the need to utilise untapped natural resources. While delivering the inaugural address, CMFRI Director Dr A Gopalakrishnan stressed the urgent need to explore marine
How is India bridging the have and have-not divide? How is India regulating health influencers? Will the markets break out of their consolidation phase soon? What is El Nino? Answers here
The brand is focused on creating premium quality, yet affordable, products to support the daily lifestyle needs of the consumers
Pre-clinical trials show no evidence of side effects in the product, which is the ninth such to be developed from marine organisms by Kochi-based CMFRI
This comes as a consequence of the deadly second wave of the Covid-19 pandemic
The CDSCO is strictly monitoring the import of such dual-use APIs for the last few months so as to get an idea on what kind of action should be taken
It will use the money to execute acquisition opportunities as part of its inorganic growth strategy